Blockade of orexin receptors in the ventral tegmental area reduced the extinction period of the lateral hypothalamic-induced conditioned place preference in rats

Behav Pharmacol. 2021 Feb 1;32(1):54-61. doi: 10.1097/FBP.0000000000000602.

Abstract

The orexinergic connection between the lateral hypothalamus (LH) and the ventral tegmental area (VTA) is involved in modulating the reward circuit. The conditioned place preference (CPP) can be induced by microinjection of carbachol, a cholinergic agonist, into the LH. The current research was conducted to understand whether intra-VTA orexin receptors (OXRs) could influence the duration of the extinction period or maintenance of the intra-LH carbachol-induced CPP. To this end, the rats unilaterally received intra-LH carbachol (250 nM) within a 3-day conditioning period. Animals that have already passed the conditioning test were unilaterally administered by intra-VTA microinjection of SB334867, an OX1R antagonist, or TCS OX2 29, an OX2R antagonist during the extinction phase of the LH stimulation-induced CPP. For the first time, our data indicated that daily intra-VTA administration of either SB334867 (30 nM) or TCS OX2 29 (10 and 30 nM) during the extinction period decreased the maintenance of intra-LH carbachol-induced CPP. In conclusion, OXRs in the VTA play crucial roles in the maintenance of reward processes.

MeSH terms

  • Animals
  • Benzoxazoles / administration & dosage
  • Benzoxazoles / pharmacology*
  • Carbachol / pharmacology
  • Cholinergic Agonists / pharmacology
  • Conditioning, Classical / drug effects
  • Dose-Response Relationship, Drug
  • Hypothalamic Area, Lateral / drug effects
  • Hypothalamic Area, Lateral / metabolism
  • Isoquinolines / administration & dosage
  • Isoquinolines / pharmacology*
  • Male
  • Naphthyridines / administration & dosage
  • Naphthyridines / pharmacology*
  • Orexin Receptor Antagonists / administration & dosage
  • Orexin Receptor Antagonists / pharmacology*
  • Orexin Receptors / drug effects*
  • Orexin Receptors / metabolism
  • Pyridines / administration & dosage
  • Pyridines / pharmacology*
  • Rats
  • Rats, Wistar
  • Reward
  • Urea / administration & dosage
  • Urea / analogs & derivatives*
  • Urea / pharmacology
  • Ventral Tegmental Area / drug effects
  • Ventral Tegmental Area / metabolism

Substances

  • 1-(2-methylbenzoxazol-6-yl)-3-(1,5)naphthyridin-4-yl urea
  • 1-(3,4-dihydro-6,7-dimethoxy-2(1H)-isoquinolinyl)-3,3-dimethyl-2-((4-pyridinylmethyl)amino)-1-butanone
  • Benzoxazoles
  • Cholinergic Agonists
  • Isoquinolines
  • Naphthyridines
  • Orexin Receptor Antagonists
  • Orexin Receptors
  • Pyridines
  • Urea
  • Carbachol